Detalles de la búsqueda
1.
Validation of the Return-to-Work Obstacles and Self-Efficacy Scale for Women on Sick Leave Due to Breast Cancer (ROSES-BC).
J Occup Rehabil
; 2024 Feb 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38311709
2.
Collaborative governance in the Quebec Cancer Network: a realist evaluation of emerging mechanisms of institutionalization, multi-level governance, and value creation using a longitudinal multiple case study design.
BMC Health Serv Res
; 19(1): 752, 2019 Oct 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-31653231
3.
Optimizing clinical and organizational practice in cancer survivor transitions between specialized oncology and primary care teams: a realist evaluation of multiple case studies.
BMC Health Serv Res
; 17(1): 834, 2017 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-29246224
4.
Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer.
Breast Cancer Res Treat
; 157(1): 109-16, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27116183
5.
Prioritizing surgery during the COVID-19 pandemic: the Quebec guidelines.
Can J Surg
; 64(1): E103-E107, 2021 02 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33599462
6.
Sunitinib in combination with trastuzumab for the treatment of advanced breast cancer: activity and safety results from a phase II study.
BMC Cancer
; 14: 166, 2014 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-24606768
7.
Building resilience in oncology teams: Protocol for a realist evaluation of multiple cases.
PLoS One
; 17(5): e0268393, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35551336
8.
Risk-Stratified Pathways for Cancer Survivorship Care: Insights from a Deliberative Multi-Stakeholder Consultation.
Curr Oncol
; 28(5): 3408-3419, 2021 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34590587
9.
Adjuvant docetaxel for node-positive breast cancer.
N Engl J Med
; 352(22): 2302-13, 2005 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-15930421
10.
Risk of adverse events with the addition of targeted agents to endocrine therapy in patients with hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis.
Cancer Treat Rev
; 62: 123-132, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29108713
11.
Safety Profile and Costs of Related Adverse Events of Trastuzumab Emtansine for the Treatment of HER2-Positive Locally Advanced or Metastatic Breast Cancer Compared to Capecitabine Plus Lapatinib from the Perspective of the Canadian Health-Care System.
Clin Drug Investig
; 35(8): 487-93, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26123628
Resultados
1 -
11
de 11
1
Próxima >
>>